PTAB Upholds Patent For Horizon's Urine Disorder Drug
The Patent Trial and Appeal Board has upheld a Horizon Therapeutics LLC patent for Ravicti, a drug that treats inborn urea cycle disorders, ruling Thursday that two generic-drug makers failed to...To view the full article, register now.
Already a subscriber? Click here to view full article